What is Eryped
ErythromycinThe Generic name of this drug
Treatment SummaryErythromycin is an antibiotic drug that stops the growth of certain bacteria. It was first discovered in 1952 and can be used to treat a variety of bacterial infections. Erythromycin is available in different forms, including IV, topical, and eye drops. It is part of the macrolide group of antibiotics, which includes azithromycin, clarithromycin, and spiramycin.
Erythrocin Stearateis the brand name
Eryped Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Erythrocin Stearate
Erythromycin
1964
261
Approved as Treatment by the FDA
Erythromycin, also known as Erythrocin Stearate, is approved by the FDA for 52 uses which include prophylaxis of Postoperative Infections and Syphilis .prophylaxis of Postoperative Infections
Syphilis
Conjunctivitis
inflammatory papular lesions
Used to treat inflammatory papular lesions in combination with Avobenzone
Pneumococcal Infections
Lower Respiratory Tract Infection (LRTI)
pustular lesions
Used to treat pustular lesions in combination with Avobenzone
Listeriosis
Acute Otitis Media caused by Haemophilus Influenzae
Used to treat Acute Otitis Media caused by Haemophilus Influenzae in combination with Sulfisoxazole
Urinary Tract Infection (UTI)
treponema pallidum infection
Listeria monocytogenes infection
Urethritis
Staphylococcal Skin Infections
Haemophilus Influenzae Infections
Used to treat Haemophilus Influenzae Infections in combination with null
Ureaplasma urealyticum
Urethritis
Intestinal amebiasis caused by entamoeba histolytica
Sulfonamides
Upper Respiratory Tract Infection
Communicable Diseases
patients with intolerance or contraindications to tetracycline use
uncomplicated endocervical infection
Pertussis
Communicable Diseases
Staphylococcus (S.) Aureus Infection
Corynebacterium Infections
diphtheria antitoxin
predominant skin comedones, papules and pustules
Used to treat predominant skin comedones, papules and pustules in combination with Tretinoin
Communicable Diseases
Legionella pneumophila
urogenital infections during pregnancy
Diphtheria
penicillins
Rheumatic Fever
Primary Syphilis
Bacterial Infections
penicillins
Erythrasma
Mycoplasma pneumoniae infection
Corynebacterium minutissimum infection
Respiratory Tract Infections
Rheumatic Fever
Streptococcus pyogenes
Chlamydia Trachomatis
Postoperative Infections
Whooping Cough
Communicable Diseases
pneumonia of infancy
Acne Vulgaris
Used to treat Acne Vulgaris in combination with Tretinoin
uncomplicated urethral infection
First episode of rheumatic fever
Effectiveness
How Eryped Affects PatientsErythromycin is an antibiotic that stops bacterial growth by preventing proteins from being made. It can be used to treat a variety of bacterial infections, but it is important to test for antibiotic resistance before administering the drug. Some strains of Haemophilus influenzae can be treated with a combination of erythromycin and sulfonamides, but Staphylococci may become resistant to erythromycin during treatment. Those taking erythromycin may experience pseudomembranous colitis, which can range from mild to life-threatening, and may also cause liver dysfunction, jaund
How Eryped works in the bodyErythromycin is an antibiotic that works by stopping bacteria from making proteins. It does this by targeting the ribosomal proteins in the cells of susceptible bacteria. This binding prevents the bacteria from forming proteins that it needs to replicate and grow, resulting in its death or control. Macrolides like erythromycin have a strong ability to bind to bacteria, which explains why they are so effective in treating a wide range of bacterial infections.
When to interrupt dosage
The dosage of Eryped is contingent upon the diagnosed condition, including Chlamydia Trachomatis, penicillins and Syphilis. The measure of dosage is dependent upon the administration procedure (e.g. Granule, for suspension or Tablet, film coated - Oral) detailed in the following table.Condition
Dosage
Administration
Communicable Diseases
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Urethritis
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
prophylaxis of Postoperative Infections
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Haemophilus Influenzae Infections
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Rheumatic Fever
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Ophthalmia neonatorum (gonococcal)
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Urethritis
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
pustular lesions
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
uncomplicated endocervical infection
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
uncomplicated urethral infection
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Acne
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
predominant skin comedones, papules and pustules
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Corynebacterium minutissimum infection
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
inflammatory papular lesions
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Chancroid
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Communicable Diseases
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Communicable Diseases
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
diphtheria antitoxin
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Lymphogranuloma Venereum
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Lower Respiratory Tract Infection (LRTI)
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Warnings
Eryped has nine recognized contraindications, so it should not be ingested when afflicted with any of the conditions presented in the table below.Eryped ContraindicationsCondition
Risk Level
Notes
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Erythromycin may interact with Toxoplasma Infections
Common Eryped Drug Interactions
Drug Name
Risk Level
Description
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Erythromycin.
Anagrelide
Major
The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Anagrelide.
Arsenic trioxide
Major
The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Arsenic trioxide.
Atorvastatin
Major
The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.
Bendamustine
Major
The serum concentration of Bendamustine can be increased when it is combined with Erythromycin.
Eryped Toxicity & Overdose RiskThe toxic dose of erythromycin in rats is 9272 mg/kg. Signs of overdosing on erythromycin include diarrhea, nausea, stomach cramps, and vomiting. If an overdose occurs, the drug should be stopped right away and any unabsorbed drug should be quickly eliminated. Supporting treatments should be given. Erythromycin cannot be completely removed from the body through dialysis.
Eryped Novel Uses: Which Conditions Have a Clinical Trial Featuring Eryped?
53 active studies are currently being conducted to investigate the potential of Eryped in providing relief from Streptococcus pyogenes, Treponema pallidum infection and Rheumatic Fever.Condition
Clinical Trials
Trial Phases
Streptococcus pyogenes
0 Actively Recruiting
Urinary Tract Infection (UTI)
24 Actively Recruiting
Phase 2, Phase 1, Phase 4, Phase 3, Not Applicable
Listeria monocytogenes infection
0 Actively Recruiting
Syphilis
6 Actively Recruiting
Phase 4, Not Applicable, Phase 3
Conjunctivitis
0 Actively Recruiting
Urethritis
0 Actively Recruiting
Gastroparesis
23 Actively Recruiting
Phase 3, Not Applicable, Phase 2, Early Phase 1
Respiratory Tract Infections
2 Actively Recruiting
Phase 3, Phase 2
Communicable Diseases
0 Actively Recruiting
pneumonia of infancy
0 Actively Recruiting
Sulfonamides
0 Actively Recruiting
Granuloma Inguinale
0 Actively Recruiting
Corynebacterium minutissimum infection
0 Actively Recruiting
Endophthalmitis
0 Actively Recruiting
penicillins
1 Actively Recruiting
Phase 4
Acne
7 Actively Recruiting
Phase 4, Early Phase 1, Not Applicable
Ureaplasma urealyticum
0 Actively Recruiting
Staphylococcal Skin Infections
1 Actively Recruiting
Phase 3
penicillins
0 Actively Recruiting
Lymphogranuloma Venereum
0 Actively Recruiting
Eryped Reviews: What are patients saying about Eryped?
1Patient Review
2/4/2011 I felt nauseous and lost my appetite.
Patient Q&A Section about eryped
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is erythromycin ethylsuccinate used to treat?
"Erythromycin is used to treat infections caused by bacteria. Additionally, it may be taken as a preventative measure to reduce the likelihood of developing certain bacterial infections. Erythromycin is in a class of antibiotics known as macrolides, which work by inhibiting the growth of bacteria."
Answered by AI
What bacteria is erythromycin used to treat?
"Erythromycin can be used to treat bacteria that causes infections of the skin and upper respiratory tract, including Streptococcus, Staphylococcus, Haemophilus, and Corynebacterium genera."
Answered by AI
How long is EryPed good for?
"After adding water to the powder, EryPed 200, EryPed 400, and EryPed Drops must be stored at 77°F (25°C) or below and used within 35 days; refrigeration is not required."
Answered by AI
What is EryPed used to treat?
"EryPed is a prescription medication used to treat Intestinal Amebiasis, Legionnaire Disease, Pertussis, Streptococcal Infections, Primary Syphilis, and Urethritis. EryPed may be used alone or combined with other medications. EryPed belongs to a class of drugs called Macrolides, which work by killing bacteria or preventing their growth."
Answered by AI